042008

Company

IGC Pharma, Inc.

Filed

May 12, 2008

Accession Number

0001074683-08-000346

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →